Logo image
STereotactic Arrhythmia Radioablation: current status of the art. The old world and the new world connected
Journal article   Open access   Peer reviewed

STereotactic Arrhythmia Radioablation: current status of the art. The old world and the new world connected

Mark Trombetta and Joost Verhoeff
Journal of radiotherapy in practice, v 22, 67
01 Jan 2023
url
https://doi.org/10.1017/S1460396922000401View
Published, Version of Record (VoR) Open

Abstract

Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging Science & Technology
In 2017, the New England Journal of Medicine published the results of the highly unusual work of Washington University of St Louis Missouri (USA), purposely treating the human heart, a theretofore organ at risk (OAR), with radiation for a non-cancerous (but malignant nonetheless) arrhythmogenic focus of ventricular tachycardia (VT). Reference Cuculich, Schill and Kashani1 This was not a complete surprise since the literature had been populated with several foundational publications over the past decade. Reference Ipsen, Blanck and Oborn2–Reference Loo, Soltys and Lei5 However, for the radiation oncology profession which spent decades avoiding direct irradiation of the heart, this was nothing short of astounding. We are now five years post-publication of the initial cohort and an estimated total number of patients treated with STereotactic Arrhythmia Radioablation (STAR) numbers still only in the hundreds of patients.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Radiology, Nuclear Medicine & Medical Imaging
Logo image